1Life Healthcare (ONEM)
One Medical has surged 168% since going public. One Wall Street analyst lays out 4 reasons investors should be skeptical of the hot primary-care company. (ONEM)
Primary-care upstart One Medical went public at the end of January, selling shares for $14 each. The stock has surged since the IPO. SVB Leerink analyst Stephen Tanal initiated coverage of One Medical on July 1, giving the stock a $36 price target and rating it market perform. There are four main risks weighing on the publicly traded primary-care company, Tanal wrote. Those include questions about its path to profitability, finding the right balance between in-person and online appointments as it grows, and facing growing competition from other healthcare disruptors. For more stories like this, sign up here for our healthcare newsletter Dispensed. We're finally getting a look at how Wall Street is thinking about a publicly-traded primary care company. Clinic-operator One Medical went public in late January. The company, founded in 2007, has long said its goal is to upend the way people got medical care by making it easy and convenient to see a doctor. The company charges a $200 annual fee for its services and bills your insurance, though its increasingly working with big employers.
1Life Healthcare (One Medical) Announces Pricing of Upsized Secondary Offering
SAN FRANCISCO, June 24, 2020 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced the pricing of an upsized…
1Life Healthcare : Your guide to lab tests
Amylase/lipase: These tests check enzymes related to pancreatic function. Basic metabolic panel : This includes tests of kidney function, electrolytes, and blood…
1Life Healthcare : What You Should Know About The Coronavirus
Updated June 22, 2020. This post will continue to be updated as more information is available. The outbreak of COVID-19, the illness caused by…
These 10 stocks have spiked more than 100% after IPOing this year
Initial public offerings have surged since March, when the broader market began to recover from the coronavirus-induced rout, according to Bespoke Group . The Renaissance IPO Index has gained nearly 78% from its March low through Friday, June 5, Bespoke said in a recent blog post. That's about double the performance of the S&P 500 in the same period. Here are the top 10 IPOs of 2020, according to Bespoke Group. All have gained more than 100% this year through June 5. Read more on Business Insider . As the market rebounds from the March coronavirus pandemic-induced rout, initial public offerings are surging, according to data from Bespoke Group. The Renaissance IPO Index , which tracks the activity of newly public companies, peaked in February and then slumped 38.2% in March, roughly in step with the broader market, Bespoke Group wrote in a Monday blog post. But from March through Friday, June 5, the index has surged nearly 78% as IPOs rush back to the market. That's roughly double the performance of the S&P 500 index in the same timeframe, according to the report.
One Medical parent 1Life Healthcare to offer $250 million in convertible bonds
1Life Healthcare Inc. undefined, parent of membership-based primary care platform One Medical, said Tuesday it is offering $250 million of convertible senior…
1Life Healthcare (One Medical) Announces Date of its First Quarter 2020 Results Conference Call
SAN FRANCISCO, May 01, 2020 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced that its first quarter 2020 results…
One Medical parent 1Life Healthcare's stock soars 38% in early trade
Shares of 1Life Healthcare Inc. soared 38% in their trading debut Friday, after the company, which operates under the name One Medical, priced its initial…
Follow Us